Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IOL Chemicals And PharmaceuticalsNSE:IOLCP -0.27%59 3-Year Book Growth Rate is 6.10% as of Jun. 2026, which is 8% below its 10-year median of 6.60. GuruFocus rates NSE:IOLCP with a GF Score™ of 59/100 and a GF Value™ of ₹101.80 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 910 Drug Manufacturers companies, IOL Chemicals And Pharmaceuticals ranks better than 55.82% on this metric.
During the past 12 months, IOL Chemicals And Pharmaceuticals's average Book Value per Share Growth Rate was 6.60% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 6.10% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 7.10% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 29.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of IOL Chemicals And Pharmaceuticals was 77.90% per year. The lowest was -24.10% per year. And the median was 6.60% per year.
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
IOL Chemicals And Pharmaceuticals 3-Year Book Growth Rate Related Terms
NSE:IOLCP vs ZTS: 3-Year Book Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IOL Chemicals And Pharmaceuticals 3-Year Book Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where IOL Chemicals And Pharmaceuticals's 3-Year Book Growth Rate falls into.
IOL Chemicals And Pharmaceuticals 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 6.10% mean?
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a 3-Year Book Growth Rate of 6.10% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for IOL Chemicals And Pharmaceuticals and its competitors. This is near median its historical median of 6.60. According to the industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #402 out of 910 companies in the Drug Manufacturers industry, placing it in the top 44.2%.
Is IOL Chemicals And Pharmaceuticals' 3-Year Book Growth Rate too high?
IOL Chemicals And Pharmaceuticals' current 3-Year Book Growth Rate of 6.10% is near median its 10-year median of 6.60. The Drug Manufacturers industry median 3-Year Book Growth Rate is 4.75. IOL Chemicals And Pharmaceuticals' value of 6.10% is 28.4% above this industry median. Based on the distribution chart, IOL Chemicals And Pharmaceuticals ranks #402 out of 910 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' 3-Year Book Growth Rate compare to ZTS?
According to the Drug Manufacturers industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #402 out of 910 companies for 3-Year Book Growth Rate. This puts IOL Chemicals And Pharmaceuticals in the upper half of its industry. The industry median 3-Year Book Growth Rate is 4.75. IOL Chemicals And Pharmaceuticals' value of 6.10% is 28.4% above this benchmark. While the company's 10-year median is 6.60 vs. the industry median of 4.75, IOL Chemicals And Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Drug Manufacturers company?
The median 3-Year Book Growth Rate among Drug Manufacturers companies is 4.75, based on 910 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IOL Chemicals And Pharmaceuticals's current 3-Year Book Growth Rate of 6.10% is 28.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for IOL Chemicals And Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median 3-Year Book Growth Rate is 4.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IOL Chemicals And Pharmaceuticals's current 3-Year Book Growth Rate is 6.10%, which is near median its own 10-year median of 6.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹101.80, compared to a current price of ₹165.58 — trading 62.7% above its estimated fair value. The current 3-Year Book Growth Rate is 6.10%, which is near median its 10-year median of 6.60 and 28.4% above the Drug Manufacturers industry median of 4.75. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current 3-Year Book Growth Rate is 6.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹165.58 is trading 62.7% above its estimated GF Value™ of ₹101.80.
GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for NSE:IOLCP:
3-Year Book Growth Rate: 6.10% (near median its 10-year median of 6.60)
GF Value™: ₹101.80 vs. price of ₹165.58 (62.7% above fair value)
Industry Position: 28.4% above the Drug Manufacturers median (#402 of 910)
No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
59GF Score
Get the complete analysis for NSE:IOLCP
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:IOLCP has been successfully added to your 
